The main goal of the thesis was to optimize the use of agonists of the FPR receptors for cancer therapy. The aim was: (1) to find the best anchor of ligands to the cancer cells and the optimal timing of the treatment, (2) to verify the universality of agonists of FPR receptors for different types of cancer, (3) to explain the synergy between ligands of FPR and ligands of TLR by flow cytometry and (4) to verify the applicability of cytotoxic test CD45+/ PI for f-MLF-DOPE ligand.

Master's thesis focuses on evalution of Stallergenes SA. Theoretical part starts with clarifying the background of the company and sector it is situated in. It is followed by outlining the principles and methods of financial analysis. Theoretical part is ended by introduction of the enterprise evaluation methods. Practical part contains strategic analysis -- characteristics of the sector, competition analysis and prediction of future development. Next, the financial analysis is performed. The evaluation is done by using book value method, discounted cash flow method and method based on EVA model.